WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research ...
News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
A new study finds that at least one Archaea has surprisingly flexibility when interpreting genetic code, which goes against a ...
Like a phoenix rising from the ashes, our skin tissue—and in fact many types of epithelial tissue that lines and covers the ...
Ginkgo Bioworks and Carnegie-Mellon University partner to develop innovative new cancer screening approach: Boston Wednesday, December 24, 2025, 16:00 Hrs [IST] Ginkgo Bioworks, a ...
Egyptian scientist Dr Nabil Seidah has won the 2025 Great Arab Minds Award for Medicine in recognition of his contributions ...
Morning Overview on MSN
A missing brain molecule could be fueling vascular dementia
Vascular dementia has long been overshadowed by Alzheimer’s disease, yet it is one of the leading causes of cognitive decline ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
Morning Overview on MSN
This rare mutation wipes brain cells, and the trigger is finally known
A vanishingly rare genetic glitch in a single enzyme can erase a newborn’s brain cells in a matter of weeks, leaving doctors ...
Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...
Study finds fatty diets reprogram liver cells, raising cancer risk Every meal you eat could be quietly shaping your liver’s future. A new study from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback